Position history for Tredje AP-fonden's holdings in VERTEX PHARMACEUTICALS INC
Tredje AP-fonden holds 131,727 shares of VRTX (VERTEX PHARMACEUTICALS INC), worth $59.7M as of 2025-Q4. The position was decreased (-28.9% shares). VRTX represents 0.4% of Tredje AP-fonden's portfolio.
Current Value
$59.7M
Current Shares
131,727
Total Value Change
+$16.8M
Total Shares Change
+40,126
Other major holders of VRTX: UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Decreased |
| 131,727 |
-28.9% |
| $59.7M |
| 0.4% |
| $453.74 |
0 |
| 2025-Q3 | Decreased | 185,312 | -26.1% | $72.6M | 0.6% | $395.31 | 0 |
| 2025-Q2 | Increased | 250,602 | +504.0% | $111.6M | 0.9% | $441.30 | 68 |
| 2025-Q1 | Decreased | 41,490 | -69.8% | $20.1M | 0.2% | $492.69 | 0 |
| 2024-Q4 | Increased | 137,452 | +6.2% | $55.4M | 0.5% | $399.35 | 37 |
| 2024-Q3 | Increased | 129,474 | +41.4% | $60.2M | 0.5% | $462.88 | 55 |
| 2024-Q2 | Decreased | 91,601 | -12.1% | $42.9M | 0.4% | $468.72 | 0 |